BioMed Research International

Current Advances in Molecular Phylogenetics

Publishing date
19 Jul 2013
Submission deadline
01 Mar 2013

1Institute for Information Transmission Problems, Russian Academy of Sciences, 119991 Moscow, Russia

2Nees-Institute for Biodiversity of Plants, University of Bonn, 53113 Bonn, Germany

Current Advances in Molecular Phylogenetics


Knowledge of phylogeny is of fundamental importance in evolutionary studies, from the reconstruction of the Tree of Life, to revealing and understanding the laws of body plan formation (the evo-devo realm), to describing the patterns and processes of microevolution. The discipline of phylogenetics has evolved radically in the new millennium, capitalizing on theoretical and methodological breakthroughs in analysis and algorithms, on the exponential increase in molecular data, and on the availability of vast computing power to enter the phylogenomic era. A solid methodological framework for phylogenomic analysis is emerging, applying data derived from whole genomes to problems in deep phylogeny, functional genomics, speciation and divergence, and phylogeography. Potential topics include, but are not limited to:

  • Evolutionary genomics
  • Molecular phylogenetics and systematics
  • Development and phylogeny (evo-devo)
  • Models, tools, and algorithms for phylogenetic reconstruction and molecular dating
  • Applied phylogenetics: genotyping and barcoding of biological objects, molecular anthropology, molecular epidemiology, and forensic science
  • Molecular ecology
  • Molecular biodiversity and biogeography

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
Impact Factor2.276

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.